• Gavi for journalists and the media

in page functions
  • Gavi delivers on its promise to tackle diarrhoea & pneumonia

  • US$ 80-100 billion

    Investing in Gavi’s 2016-2020 strategy has the potential to deliver US$ 80-100 billion in costs averted related to illness, such as productivity loss due to death/disability, treatment costs, caretaker productivity loss and transport costs.

    Stack M et al. Estimated economic benefits during Decade of Vaccines, Health Affairs 2011

    More facts...

  • Press briefing archive 

    27 September 2011 - GAVI press conference following announcement of vaccine funding for 37 more countries 


close icon

modal window here